Yale Cancer Center Researchers Discover Mechanism to Overcome Drug Resistance in B-Cell Acute Lymphoblastic Leukemia
February 03, 2021
February 03, 2021
NEW HAVEN, Connecticut, Feb. 3 (TNSJou) -- Yale School of Medicine issued the following news on Feb. 1, 2021:
In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease. The findings were published online today in the Proceedings of the National Academy of Sciences (PNAS).
B cells are effector cells of the . . .
In a new study led by Yale Cancer Center, researchers have discovered a novel metabolic gatekeeper mechanism for leukemia. This mechanism depends on a molecule called PON2, which could lead to a new treatment for the disease. The findings were published online today in the Proceedings of the National Academy of Sciences (PNAS).
B cells are effector cells of the . . .